Skip to main content
SpringerLink
Log in

Therapeutic Potentials of Adrenomedullin for Heart Failure and Pulmonary Hypertension

  • Chapter
Adrenomedullin in Cardiovascular Disease

Part of the book series: Basic Science for the Cardiologist ((BASC,volume 19))

  • 391 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Archer S, and Rich S. (2000) Primary pulmonary hypertension: a vascular biology and transnational research &quote;Work in progress&quote;. Circulation 102:2781–2791.

    PubMed  Google Scholar 

  • Barest RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, and Brundage BH, et al. (1996) A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 334:296–302.

    Article  PubMed  Google Scholar 

  • Brenner BM, Ballermann BJ, Gunning ME, and Zeidel ML. (1990) Diverse biological actions of natriuretic peptide. Physiol Rev 70:665–699.

    PubMed  Google Scholar 

  • Champion HC, Bivalacqua TJ, Toyoda K, Heistad DD, Hyman AL, and Kadowitz PJ. (2000) In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxia-induced pulmonary hypertension in the mouse. Circulation 101:923–930.

    PubMed  Google Scholar 

  • Clementi G, Caruso A, Cutuli VM, Prato A, Mangano NG, and Amico-Roxas M. (1999) Antiinflammatory activity of adrenomedullin in the acetic acid peritonitis in rats. Life Sci 65:PL203–208.

    Article  PubMed  Google Scholar 

  • Edwards RM, Trizna W, Stack E, and Aiyar N. (1996) Effect of adrenomedullin on cAMP levels along the rat nephron: comparison with CGRP. Am J Physiol 271:F895–F899.

    PubMed  Google Scholar 

  • Heaton J, Lin B, Chang JK, Steinberg S, Hyman A, and Lippton H. (1995) Pulmonary vasodilation to adrenomedullin: a novel peptide in humans. Am J Physiol 268:H2211–2215.

    PubMed  Google Scholar 

  • Hoeper MM, Schwarze M, Ehlerding S, Adler-Schuermeyer A, Spiekerkoetter E, Niedermeyer J, Hamm M, and Fabel H. (2000) Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med 342:1866–1870.

    Article  PubMed  Google Scholar 

  • Horio T, Kohno M, Kano H, Ikeda M, Yasunari K, Yokokawa K, Minami M, and Takeda T. (1995) Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells. Circ Res 77:660–664.

    PubMed  Google Scholar 

  • Kakishita M, Nishikimi T, Okano Y, Satoh T, Kyotani S, Nagaya N, Fukushima K, Nakanishi N, Takishita S, Miyata A, Kangawa K, Matsuo H, and Kunieda T. (1999) Increased plasma levels of adrenomedullin in patients with pulmonary hypertension. Clin Sci (Lond) 96:33–39.

    Google Scholar 

  • Kano H, Kohno M, Yasunari K, Yokokawa K, Horio T, Ikeda M, Minami M, Hanehira T, Takeda T, and Yoshikawa J. (1996) Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells. J Hypertens 14:209–213.

    PubMed  Google Scholar 

  • Kim W, Moon SO, Sung MJ, Kim SH, Lee S, Kim HJ, Koh GY, and Park SK. (2002) Protective effect of adrenomedullin in mannitol-induced apoptosis. Apoptosis 7:527–535.

    Article  PubMed  Google Scholar 

  • Lippton H, Chang J-K, Hao Q, Summer W, and Hyman AL. (1994) Adrenomedullin dilates the pulmonary vascular bed in vivo. J Appl Physiol 76:2154–2156.

    PubMed  Google Scholar 

  • Majid DS, Kadowitz PJ, Coy DH, Navar LG. (1996) Renal responses to intra-arterial administration of adrenomedullin in dogs. Am J Physiol. 1996;270:F200–205.

    PubMed  Google Scholar 

  • McLaughlin VV, Genthner DE, Panella MM, and Rich S. (1998) Reduction 212 in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 338:273–277.

    Article  PubMed  Google Scholar 

  • Nagaya N, Kyotani S, Uematsu M, Ueno K, Oya H, Nakanishi N, Shirai M, Mori H, Miyatake K, and Kangawa K. (2004) Effects of adrenomedullin inhalation on hemodynamics and exercise capacity in patients with idiopathic pulmonary artenrial hypertension. Circulation 109:351–356.

    Article  PubMed  Google Scholar 

  • Nagaya N, Okumura H, Uematsu M, Shimizu W, Ono F, Shirai M, Mori H, Miyatake K, and Kangawa K. (2003) Repeated inhalation of adrenomedullin ameliorates pulmonary hypertension and survival in monocrotaline rats. Am J Physiol Heart Circ Physiol 285:H2125–2131.

    PubMed  Google Scholar 

  • Nagaya N, Satoh T, Nishikimi T, Uematsu M, Furuichi S, Sakamaki F, Oya H, Kyotani S, Nakanishi N, Goto Y, Masuda Y, Miyatake K, and Kangawa K. (2000a) Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation 101:498–503.

    PubMed  Google Scholar 

  • Nagaya N, Nishikimi T, Uematsu M, Satoh T, Oya H, Kyotani S, Sakamaki F, Ueno K, Nakanishi N, Miyatake K, and Kangawa K. (2000b) Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension. Heart 84:653–658.

    Article  PubMed  Google Scholar 

  • Nakamura M, Yoshida H, Makita S, Arakawa N, Niinuma H, and Hiramori K. (1997) Potent and long-lasting vasodilatory effects of adrenomedullin in humans: comparisons between normal subjects and patients with chronic heart failure. Circulation 95:1214–1221.

    PubMed  Google Scholar 

  • Nishikimi T, Saito Y, Kitamura K, Ishimitsu T, Eto T, Kangawa K, Matsuo H, Omae T, and Matsuoka H. (1995) Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol 26:1424–1431.

    Article  PubMed  Google Scholar 

  • Nishikimi T, Horio T, Sasaki T, Yoshihara F, Takishita S, Miyata A, Matsuo H, Kangawa K. (1997) Cardiac production and secretion of adrenomedullin are increased in heart failure. Hypertension. 30:1369–1375.

    PubMed  Google Scholar 

  • Nossaman BD, Feng CJ, Kaye AD, DeWitt B, Coy DH, Murphy WA, and Kadowitz PJ. (1996) Pulmonary vasodilator responses to adrenomedullin are reduced by NOS inhibitors in rats but not in cats. Am J Physiol 270:L782–789.

    PubMed  Google Scholar 

  • Okumura H, Nagaya N, Itoh T, Okano I, Hino J, Mori K, Tsukamoto Y, Ishibashi-Ueda H, Miwa S, Tambara K, Toyokuni S, Yutani C, and Kangawa K. (2004) Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway. Circulation 109:242–248.

    Article  PubMed  Google Scholar 

  • Owji AA, Smith DM, Coppock HA, Morgan DG, Bhogal R, Ghatei MA, and Bloom SR. (1995) An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology 136:2127–2134.

    Article  PubMed  Google Scholar 

  • Oya H, Nagaya N, Furuichi S, Nishikimi T, Ueno K, Nakanishi N, Yamagishi M, Kangawa K, and Miyatake K. (2000) Comparison of intravenous adrenomedullin with atrial natriuretic peptide in patients with congestive heart failure. Am J Cardiol. 86:94–98.

    Article  PubMed  Google Scholar 

  • Parkes DG, and May CN. (1997) Direct cardiac and vascular actions of adrenomedullin in conscious sheep. Br J Pharmacol 120:1179–1185.

    PubMed  Google Scholar 

  • Pasque MK, Trulock EP, Kaiser LR, and Cooper JD. (1991) Single lung transplantation for pulmonary hypertension: three month hemodynamic follow-up. Circulation 84:2275–2279.

    PubMed  Google Scholar 

  • Rademaker MT, Charles CJ, Lewis LK, Yandle TG, Cooper GJ, Coy DH, Richards AM, and Nicholls MG. (1997) Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. Circulation 96:1983–1990.

    PubMed  Google Scholar 

  • Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, and Koerner SK. (1987) Primary pulmonary hypertension: a national prospective study. Ann Intem Med 107:216–223.

    Google Scholar 

  • Szokodi I, Kinnunen P, Tavi P, Weckstrom M, Toth M, and Ruskoaho H. (1998) Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide. Circulation 97:1062–1070.

    PubMed  Google Scholar 

  • Tokunaga N, Nagaya N, Shirai M, Tanaka E, Ishibashi-Ueda H, Harada-Shiba M, Kanda M, Ito T, Shimizu W, Tabata Y, Uematsu M, Nishigami K, Sano S, Kangawa K, and Mori H. (2004) Adrenomedullin gene transfer induces therapeutic angiogenesis in a rabbit model of chronic hindlimb ischemia: benefits of a novel nonviral vector, gelatin. Circulation 109:526–531.

    Article  PubMed  Google Scholar 

  • Tsuruda T, Kato J, Kitamura K, Kawamoto M, Kuwasako K, Imamura T, Koiwaya Y, Tsuji T, Kangawa K, and Eto T. (1999) An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth. Cardiovasc Res. 43:958–967.

    Article  PubMed  Google Scholar 

  • Tsuruda T, Kato J, Kitamura K, Kuwasako K, Imamura T, Koiwaya Y, Tsuji T, Kangawa K, and Eto T. (1998) Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes. Hypertension 31:505–510.

    PubMed  Google Scholar 

  • Yamaguchi T, Baba K, Doi Y, and Yano K. (1995) Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomerulosa cells. Life Sci 56:379–387.

    Article  PubMed  Google Scholar 

  • Yoshibayashi M, Kamiya T, Kitamura K, Saito Y, Kangawa K, Nishikimi T, Matsuoka H, Eto T, and Matsuo H. (1997) Plasma levels of adrenomedullin in primary and secondary pulmonary hypertension in patients < 20 years of age. Am J Cardiol 79:1556–1558.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Osaka, Japan

    Noritoshi Nagaya

  2. Department of Hypertension and Cardiorenal Medicine, Dokkyo University School of Medicine, Mibu, Tochigi, Japan

    Toshio Nishikimi

  3. Department of Biochemistry, National Cardiovascular Center Research Institute, Osaka, Japan

    Kenji Kangawa

Authors
  1. Noritoshi Nagaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshio Nishikimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kenji Kangawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Hypertension and Cardiorenal Medicine, Dokkyo University School of Medicine, Mibu, Tochigi, Japan

    Toshio Nishikimi MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Nagaya, N., Nishikimi, T., Kangawa, K. (2005). Therapeutic Potentials of Adrenomedullin for Heart Failure and Pulmonary Hypertension. In: Nishikimi, T. (eds) Adrenomedullin in Cardiovascular Disease. Basic Science for the Cardiologist, vol 19. Springer, Boston, MA. https://doi.org/10.1007/0-387-25405-6_12

Download citation

  • DOI: https://doi.org/10.1007/0-387-25405-6_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-25404-3

  • Online ISBN: 978-0-387-25405-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation